These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 33105493)

  • 1. Stem Cell Therapy for Parkinson's Disease.
    Han F; Hu B
    Adv Exp Med Biol; 2020; 1266():21-38. PubMed ID: 33105493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of stem cell-based therapy for Parkinson's disease.
    Han F; Baremberg D; Gao J; Duan J; Lu X; Zhang N; Chen Q
    Transl Neurodegener; 2015; 4():16. PubMed ID: 26339485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
    Chen W; Huang Q; Ma S; Li M
    ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Han F; Wang W; Chen B; Chen C; Li S; Lu X; Duan J; Zhang Y; Zhang YA; Guo W; Li G
    Cytotherapy; 2015 May; 17(5):665-79. PubMed ID: 25747741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
    Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cells and Parkinson's disease: modelling and treatment.
    Xu X; Huang J; Li J; Liu L; Han C; Shen Y; Zhang G; Jiang H; Lin Z; Xiong N; Wang T
    Cell Prolif; 2016 Feb; 49(1):14-26. PubMed ID: 26748765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replacing what's lost: a new era of stem cell therapy for Parkinson's disease.
    Fan Y; Winanto ; Ng SY
    Transl Neurodegener; 2020; 9():2. PubMed ID: 31911835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced dopaminergic neurons: A new promise for Parkinson's disease.
    Xu Z; Chu X; Jiang H; Schilling H; Chen S; Feng J
    Redox Biol; 2017 Apr; 11():606-612. PubMed ID: 28110217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical translation of stem cell transplantation in Parkinson's disease.
    Lindvall O
    J Intern Med; 2016 Jan; 279(1):30-40. PubMed ID: 26332959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases.
    Pan-Montojo F; Funk RH
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):907-20. PubMed ID: 23131153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem Cell Therapy for the Treatment of Parkinson's Disease: What Promise Does it Hold?
    Nasrolahi A; Shabani Z; Sadigh-Eteghad S; Salehi-Pourmehr H; Mahmoudi J
    Curr Stem Cell Res Ther; 2024; 19(2):185-199. PubMed ID: 36815638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Approaches and Molecular Mechanisms for Directly Reprogramming Fibroblasts Into Neurons and Dopamine Neurons.
    Han F; Liu Y; Huang J; Zhang X; Wei C
    Front Aging Neurosci; 2021; 13():738529. PubMed ID: 34658841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell therapy for Parkinson's disease: Functional role of the host immune response on survival and differentiation of dopaminergic neuroblasts.
    Wenker SD; Leal MC; Farías MI; Zeng X; Pitossi FJ
    Brain Res; 2016 May; 1638(Pt A):15-29. PubMed ID: 26239914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for bringing stem cell-derived dopamine neurons to the clinic-The NYSTEM trial.
    Studer L
    Prog Brain Res; 2017; 230():191-212. PubMed ID: 28552229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research progress of neural stem cells as a source of dopaminergic neurons for cell therapy in Parkinson's disease.
    Zhang L; Yang H
    Mol Biol Rep; 2024 Feb; 51(1):347. PubMed ID: 38400887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Developments in Cell Replacement Therapy for Parkinson's Disease.
    Guo X; Tang L; Tang X
    Neuroscience; 2021 May; 463():370-382. PubMed ID: 33774124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, characterization, and banking of clinical-grade cells for neural transplantation: Scale up, fingerprinting, and genomic stability of stem cell lines.
    Natalwala A; Kunath T
    Prog Brain Res; 2017; 230():133-150. PubMed ID: 28552226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engraftable Induced Pluripotent Stem Cell-Derived Neural Precursors for Brain Repair.
    Zygogianni O; Kouroupi G; Taoufik E; Matsas R
    Methods Mol Biol; 2020; 2155():23-39. PubMed ID: 32474865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cotransplantation of NSCs and ethyl stearate promotes synaptic plasticity in PD rats by Drd1/ERK/AP-1 signaling pathway.
    Yi L; Ma H; Yang X; Zheng Q; Zhong J; Ye S; Li X; Chen D; Li H; Li C
    J Ethnopharmacol; 2024 Mar; 321():117292. PubMed ID: 37806537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.